Significant amounts of scarce resources are devoted to medical research, but there have been few attempts to assess whether the benefits to society of these investments exceed the costs.
A method for undertaking such an assessment has been developed and applied retrospectively to the Diabetic Retinopathy Study, a major clinical trial funded by the National Eye Institute from 1972-1981.
It was estimated that the trial, which cost 810.5 million, generated a net saving of $2816 million to society ($231 million when the costs of lost production are excluded) (1982 prices) and a gain to patients of 279,000 vision years.
Mots-clés Pascal : Diabète, Rétinopathie, Oeil pathologie, Complication, Essai clinique, Recherche scientifique, Evaluation, Analyse coût efficacité, Economie santé, Endocrinopathie, Arbre décision, Méthodologie, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Diabetes mellitus, Retinopathy, Eye disease, Complication, Clinical trial, Scientific research, Evaluation, Cost efficiency analysis, Health economy, Endocrinopathy, Decision tree, Methodology, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 92-0355250
Code Inist : 002B21E02B. Création : 199406.